T1	Intervention 52 127	postmenopausal women with advanced, hormone-receptor-positive breast cancer
T2	Intervention 556 588	outpatient clinics and hospitals
T3	Intervention 602 743	postmenopausal women with hormone-receptor-positive, locally advanced or metastatic breast cancer previously treated with endocrine treatment
